In a preclinical study, XmAb143 (IL18-Fc) promoted NK and T lymphocyte expansion and IFN-γ secretion in huPBMC-engrafted NSG mice (GvHD model) and demonstrated tumor growth inhibition, T-cell proliferation and activation in CD34+ humanized mice (160). Here, IL18 is linked to neoplasm.